Centerpoint Advisors, LLC Eli Lilly & CO Transaction History

Centerpoint Advisors, LLC

$278 Million
Q2 2024

A detailed history of Centerpoint Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Centerpoint Advisors, LLC holds 3,444 shares of LLY stock, worth $3.11 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares

3,444

Previous 3,428 0.47%

Holding current value

$3.11 Million

Previous $2.67 Million 16.91%

% of portfolio

1.12%

Previous 1.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$724.87 - $909.04 $11,597 - $14,544	16 Added 0.47%	3,444 $3.12 Million
Q1 2024 May 02, 2024	SELL	$592.2 - $792.28 $2,961 - $3,961	-5 Reduced 0.15%	3,428 $2.67 Million
Q4 2023 Jan 16, 2024	SELL	$525.19 - $619.13 $175,938 - $207,408	-335 Reduced 8.89%	3,433 $2 Million
Q3 2023 Nov 01, 2023	SELL	$434.7 - $599.3 $196,919 - $271,482	-453 Reduced 10.73%	3,768 $2.02 Million
Q2 2023 Jul 17, 2023	SELL	$350.74 - $468.98 $67,342 - $90,044	-192 Reduced 4.35%	4,221 $1.98 Million
Q1 2023 May 03, 2023	BUY	$310.63 - $364.82 $98,780 - $116,012	318 Added 7.77%	4,413 $1.52 Million
Q4 2022 Jan 24, 2023	BUY	$321.55 - $374.67 $51,448 - $59,947	160 Added 4.07%	4,095 $1.5 Million
Q3 2022 Oct 13, 2022	BUY	$296.48 - $337.87 $941,324 - $1.07 Million	3,175 Added 417.76%	3,935 $1.27 Million
Q4 2021 Jan 14, 2022	SELL	$224.85 - $279.04 $24,058 - $29,857	-107 Reduced 12.34%	760 $210,000
Q2 2020 Jul 31, 2020	SELL	$136.42 - $164.18 $8,867 - $10,671	-65 Reduced 6.97%	867 $142,000
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $30,885 - $35,447	-408 Reduced 30.45%	932 $80,000
Q1 2018 May 09, 2018	BUY	$74.21 - $87.6 $1,929 - $2,277	26 Added 1.98%	1,340 $104,000
Q4 2017 Mar 14, 2018	BUY	$81.94 - $87.89 $107,669 - $115,487	1,314	1,314 $111,000

Others Institutions Holding LLY

# of Institutions

3,865

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $858B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centerpoint Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Centerpoint Advisors, LLC with notifications on news.

Account

Centerpoint Advisors, LLC Eli Lilly & CO Transaction History